Effect of Gastrogastric Fistula Closure in Type 2 Diabetes
Roux-en-Y gastric bypass (RYGB) has been shown to significantly improve glucose control in patients with type 2 diabetes (T2DM). The formation of a gastrogastric fistula (GGF) allows nutrients to pass through the native route, rather than bypassing the duodenum in typical RYGB configuration. We sought to evaluate the effect of revisional bariatric surgery for known GGF on control of diabetes.
A retrospective chart review of a single academic institution was performed to identify patients who had T2DM at the time of corrective surgery for a GGF. Baseline characteristics, and postoperative outcomes including changes in body mass index (BMI), glycated hemoglobin, fasting blood glucose (FBG), and diabetes medications were assessed.
Ten patients were identified with GGF who had T2DM at the time of corrective surgery. Patients had a male-to-female ratio of 2:3, a mean age of 59.2 ± 10 years, a mean baseline BMI of 38.1 ± 17.6 kg/m2, and a median duration of 9 years (interquartile range 6–14) from initial RYGB to revision. At a mean follow-up of 14.9 ± 8.5 months, a mean reduction in BMI of 4.9 ± 6 kg/m2 was associated with a significant mean reduction in FBG (167.1 ± 88.2 vs. 106.1 ± 20.4 mg/dL, p = 0.04) and number of diabetes medications (1.4 ± 0.8 vs. 0.7 ± 0.7, p = 0.04).
In patients with diabetes and GGF, a corrective surgery for closure of fistula and restoration of bypass anatomy results in improvement of glucose control and status of diabetes medications. This finding can highlight the potential metabolic significance of duodenal exclusion.
KeywordsRoux-en-Y gastric bypass Gastrogastric fistula Revisional surgery Complication Diabetes Glycemic control Glucose control
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
For this type of study, formal consent is not required.
Does not apply.
- 3.Yan J, Cohen R, Aminian A. Reoperative bariatric surgery for treatment of type two diabetes mellitus. Surg Obes Relat Dis. 2017; https://doi.org/10.1016/jsoard201704.019.
- 4.Abu-Elmagd KM, Costa G, McMichael D, et al. Autologous reconstruction and visceral transplantation for management of patients with gut failure after bariatric surgery: 20 years of experience. Ann Surg. 2015;252:586–601.Google Scholar
- 18.Hutch CR, Sandoval DA. Physiology and molecular responses to bariatric surgery: marker or mechanisms underlying T2DM resolution? Ann N Y Acad Sci. 2016:1–15.Google Scholar